Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis

Summary

This was a double-blinded, two-arm, phase 2a study to assess efficacy, safety and tolerability of DFV890 in participants with symptomatic knee osteoarthritis.

Timeline

Start

2021-09-20

Primary completion

2024-12-14

Completion

2024-12-23

Drugs

Indications